Paper2183158
Presence of mutations in all three ras genes in human thyroid tumors.
Suarez HG and 7 others. Oncogene, 1990. Cited by 259 papers, by iCite.
Cite this record
ConductScience Library. Presence of mutations in all three ras genes in human thyroid tumors. Papers, record 2183158. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2183158
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Genes, ras | Major topic |
| Mutation | Major topic |
| Thyroid Neoplasms | Major topic |
| Adenoma | |
| Adolescent | |
| Adult | |
| Aged | |
| Base Sequence | |
| Carcinoma | |
| DNA, Neoplasm | |
| Female | |
| Humans | |
| Male | |
| Middle Aged | |
| Molecular Sequence Data | |
| Nucleic Acid Hybridization | |
| Oligonucleotide Probes | |
| Polymerase Chain Reaction |
Source PubMed
Cited by74
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 259 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40762994 | Revisionist history uncovers a simplified molecular-based classification of differentiated thyroid cancer. | J Pathol | 2025 | https://conductscience.org/library/papers/40762994 | PubMed |
| 40103874 | The correlation between the ultrasound examination parameters and the pathological characteristics of papillary thyroid carcinomas. | Pak J Med Sci | 2025 | https://conductscience.org/library/papers/40103874 | PubMed |
| 35884820 | Genetic Changes in Thyroid Cancers and the Importance of Their Preoperative Detection in Relation to the General Treatment and Determination of the Extent of Surgical Intervention-A Review. | Biomedicines | 2022 | https://conductscience.org/library/papers/35884820 | PubMed |
| 35003743 | Variations in MAP kinase gladiators and risk of differentiated thyroid carcinoma. | Mol Clin Oncol | 2022 | https://conductscience.org/library/papers/35003743 | PubMed |
| 34359735 | PRKAR1A and Thyroid Tumors. | Cancers (Basel) | 2021 | https://conductscience.org/library/papers/34359735 | PubMed |
| 32163919 | GABPA-dependent down-regulation of DICER1 in follicular thyroid tumours. | Endocr Relat Cancer | 2020 | https://conductscience.org/library/papers/32163919 | PubMed |
| 30815568 | Analysis of RAS mutation in thyroid nodular hyperplasia and follicular neoplasm in a Korean population. | Endocrinol Diabetes Metab | 2018 | https://conductscience.org/library/papers/30815568 | PubMed |
| 30766126 | New Treatment Options for Metastatic Thyroid Cancer. | Fed Pract | 2015 | https://conductscience.org/library/papers/30766126 | PubMed |
| 30717910 | Coding Molecular Determinants of Thyroid Cancer Development and Progression. | Endocrinol Metab Clin North Am | 2019 | https://conductscience.org/library/papers/30717910 | PubMed |
| 29556290 | Identification of a novel HRAS variant and its association with papillary thyroid carcinoma. | Oncol Lett | 2018 | https://conductscience.org/library/papers/29556290 | PubMed |
| 29455653 | Novel targeted therapies and immunotherapy for advanced thyroid cancers. | Mol Cancer | 2018 | https://conductscience.org/library/papers/29455653 | PubMed |
| 27236916 | Genomic Profiling of Thyroid Cancer Reveals a Role for Thyroglobulin in Metastasis. | Am J Hum Genet | 2016 | https://conductscience.org/library/papers/27236916 | PubMed |
| 27042004 | Selective use of sorafenib in the treatment of thyroid cancer. | Drug Des Devel Ther | 2016 | https://conductscience.org/library/papers/27042004 | PubMed |
| 25999051 | Analysis of RAS mutation and PAX8/PPARγ rearrangements in follicular-derived thyroid neoplasms in a Korean population: frequency and ultrasound findings. | J Endocrinol Invest | 2015 | https://conductscience.org/library/papers/25999051 | PubMed |
| 25268744 | Oncogenic RAS-induced senescence in human primary thyrocytes: molecular effectors and inflammatory secretome involved. | Oncotarget | 2014 | https://conductscience.org/library/papers/25268744 | PubMed |
| 24829266 | Molecular approaches to thyroid cancer diagnosis. | Endocr Relat Cancer | 2014 | https://conductscience.org/library/papers/24829266 | PubMed |
| 24247220 | Deregulation of microRNA expression in thyroid neoplasias. | Nat Rev Endocrinol | 2014 | https://conductscience.org/library/papers/24247220 | PubMed |
| 24099521 | Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues. | BMC Med Genomics | 2013 | https://conductscience.org/library/papers/24099521 | PubMed |
| 23946782 | DNA methylation state of the galectin-3 gene represents a potential new marker of thyroid malignancy. | Oncol Lett | 2013 | https://conductscience.org/library/papers/23946782 | PubMed |
| 23933154 | Genetics and epigenetics of sporadic thyroid cancer. | Mol Cell Endocrinol | 2014 | https://conductscience.org/library/papers/23933154 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2183158
GET https://conductscience.org/api/papers/v1/2183158/cited_by?page=2